Login to Your Account



Deals And M&A NEWS

Google's life sciences team is once again delving into the diabetes space, this time through a partnership with Sanofi SA, of Paris. 

Takeda Pharmaceutical Co. Ltd. and Nanotherapeutics Inc. have struck an agreement providing Takeda with expanded commercialization and technology rights to Nanotherapeutics' Vero cell technology, a manufacturing platform that's key to Takeda's flu vaccines and its aspirations to further develop its global vaccines business in other markets.

An exclusive new tie-up between Janus Biotherapeutics Inc. and Roche AG will advance what could become the first oral TLR inhibitor to enter the clinic with the potential to address autoimmune diseases.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: